Roche suspends investments in Germany over drug pricing reform
Swiss pharmaceutical giant Roche announced a freeze on all future investment decisions in Germany. Head of Roche Germany Daniel Steiner linked the move to government policies that have undermined the industry's trust. The criticism came on the opening day of the government's investment summit in Berlin.
Dilnoza Rahimova